Canada Clears Novartis-Alcon Deal With Divestitures
Canada's competition watchdog signed off on Novartis AG's acquisition of a majority stake in Alcon Laboratories Inc. on Monday after Novartis agreed to sell off some of its eye care assets,...To view the full article, register now.
Already a subscriber? Click here to view full article